Akums Group Secures €200 Million Deal to Expand in Europe

Akums Group, India's largest contract manufacturing company, has signed a €200 million (Rs 1,760 crore) deal with a global pharmaceutical company to produce and supply pharmaceutical products for the European market.

Akums will receive an upfront payment of €100 million (Rs 880 crore) to help with product development and secure European regulatory approvals for its oral liquid manufacturing facility.

The partnership will involve producing different oral liquid formulations at Akums' facilities in India, which will be marketed across Europe by the partner company.

Akums' partnership reflects its commitment to strengthening its presence in Europe and other regulated markets, aligning with its long-term strategic objectives. By supporting India 'Make in India' initiative Akums aims to boost its domestic manufacturing capabilities for global markets. The company currently operates two European-approved facilities for injectables and oral solids.

With this new approval, Akums plans to expand its portfolio in Europe by adding oral liquid formulations to its existing range, which includes tablets, hard gelatin capsules, sachets, ampoules, vials, eye drops, and dry powder injections. Commercial supply of these products is expected to begin in 2027 and continue until 2032. 

Additionally, Akums will initiate the European approval process for its oral liquid manufacturing facility, with the expectation that site and product dossier approvals will be secured by the end of 2026.

Sandeep Jain Managing Director of Akums Group said “This collaboration is a testament to our manufacturing excellence and world-class R&D capabilities Manufacturing these products in India not only optimizes costs for global pharma companies but also strengthens their supply chains. This partnership opens doors for further collaborations and underscores our commitment to regulated markets.” 

Advertisment

Sanjeev Jain, Managing Director of Akums, said, “It gives us immense pleasure to collaborate with one of the largest multinational pharma companies. This partnership allows us to replicate our domestic CDMO success globally and expand our footprint in Europe’s regulated markets.” 

About Akums Group

Akums Drugs & Pharmaceuticals Ltd. is one of the leading contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s domestically consumed medicines. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments.